New rules and guidance must name any approved overdose reversal drug
To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes, section 210, Sec. 210.
Written by .
New rules and guidance must name any approved overdose reversal drug
The document says “shall”Who acts: Secretary of Health and Human ServicesHow: statuteSec. 210 in the PDF
What the document says
“The Secretary of Health and Human Services shall ensure that, as appropriate, whenever the Department of Health and Human Services issues a regulation or guidance for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal drug (such as a reference to naloxone) is inclusive of any opioid overdose reversal drug that has been approved under section 505 of the Federal Food, Drug, and Cosmetic Act”
The section requires the Secretary to ensure that, in new regulations or guidance for any grant program addressing opioid misuse and use disorders, a reference to an overdose reversal drug such as naloxone covers any approved overdose reversal drug for emergency treatment of a known or suspected opioid overdose.
What the document actually says
“The Secretary of Health and Human Services shall ensure that, as appropriate, whenever the Department of Health and Human Services issues a regulation or guidance for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal drug (such as a reference to naloxone) is inclusive of any opioid overdose reversal drug that has been approved under section 505 of the Federal Food, Drug, and Cosmetic Act”
That sentence, in plain words
New rules and advice must not name only one drug. If they name naloxone, they must cover the others too. Any approved reversal drug counts.
What this is about
Naloxone was the first drug to reverse an opioid overdose. Others have since been approved. Naming only the first can leave the newer ones out.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.
Reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, Public Law 119-44, sec. 210, 139 Stat. 682 (2025). https://www.govinfo.gov/content/pkg/PLAW-119publ44/html/PLAW-119publ44.htm
This page
“New rules and guidance must name any approved overdose reversal drug,” Reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, section 210, Sec. 210. Read the Mandate, https://readthemandate.org/pl-119-44/proposal/sec210-inclusive-references/ (retrieved October 10, 2026).
Cite the document when the claim is about what the document says. Cite this page when the indexing, the wording or the record of what has happened is what is being relied on.
How to Read This Page
The quotation is the document's own words, exactly as printed, checked against the page
number against the Act itself before publishing. The paragraph underneath is our summary,
not the document's words. So is the plain English version, which is why it sits beside the
quotation rather than replacing it.
